Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis Patients
Clinical trial NCT05902429 · UNKNOWN
Trial details
- NCT number
- NCT05902429
- Sponsor
- Pontificia Universidade Católica do Rio Grande do Sul
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2024-08-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.